PBV.F Prestige Consumer Healthcare Inc

Healthcare Pharmaceuticals Frankfurt Exchange
41.80 EUR
Close of Nov 13, 2026
37.00 60.00
Market cap
EUR 1.98B
P/E
15.0x
P/B
1.06x
ROE
5.6%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Sep 2026.

Is PBV.F undervalued?

Graham number
Price41.80
Graham value49.84
Discount16.1%

PBV.F trades 16.1% below its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Prestige Consumer Healthcare Inc fundamental analysis

No fundamental analysis for Prestige Consumer Healthcare Inc yet.

Prestige Consumer Healthcare Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Prestige Consumer Healthcare Inc

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally. It operates in two segments, North American OTC Healthcare and International OTC Healthcare. The company offers analgesic powders under the BC and Goody's brand; various diaper rash treatments and skin protectants for babies under the Boudreaux's Bu…

Full company profile